Press release
eClinical Solutions Market worth $22.1 billion by 2029 driven by Rising Chronic Illness Rates
Asia-Pacific market was the fastest growing market, however, the growth was backed by the emerging pharmaceutical companies, clinical trial activity and increased healthcare expenditure in countries such as China and India.
The global eClinical Solutions Market [https://www.marketsandmarkets.com/Market-Reports/eclinical-solutions-market-553.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] is expected to grow from USD 11.6 billion in 2024 to USD 22.1 billion by 2029, at a CAGR of 13.7%. eClinical solutions have significantly enhanced clinical trial efficiency, site performance, and cost-effectiveness compared to traditional methods, driving their market growth. These solutions, including electronic data capture (EDC) and clinical data management systems (CDMS), streamline operations and ensure regulatory compliance, benefiting contract research organizations (CROs), researchers, and pharmaceutical companies. Despite high implementation costs and concerns over patient privacy, the market is expanding due to increased adoption of novel software, rising clinical trials in developing countries, and the growing need for efficient data management. The electronic clinical outcome assessment (eCOA) solutions segment is expected to grow the fastest, driven by improved data accuracy and patient engagement. Web-hosted and cloud-based models currently dominate the market due to their flexibility and security features. North America led the market in 2023, while Asia Pacific is projected to experience the highest growth rate during the forecast period, driven by a burgeoning healthcare sector and increasing clinical trials. Key market players include Medidata, Veeva Systems, IQVIA, ICON plc, and Oracle.
Download PDF Brochure: [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=553&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]
Browse in-depth TOC on "eClinical Solutions Market"
317 - Tables
54 - Figures
244 - Pages
Medidata (A Dassault Systemes Company): Leader in End-to-End Clinical Data Management
Medidata excels in global clinical data capture and management with extensive functionality tailored for diverse clinical study needs. The company's robust market position is reinforced by its comprehensive organic development efforts, including the release of the myMedidata app in December 2022. This native mobile app enhances patient experience by offering features such as electronic diaries, patient-reported outcomes, and informed consent through a single sign-on. This innovation aims to improve patient engagement and data quality by providing easy access to trial activities from smartphones. Medidata also strengthens its market presence through strategic partnerships, collaborations, and acquisitions.
Veeva Systems: Premier Provider of Cloud Solutions for Life Sciences
Veeva Systems is a leading provider of cloud-based solutions tailored to the global life sciences sector, offering software, data, and consulting services across critical business areas from R&D to commercialization. The company's revenue is derived from two main product categories: Commercial Solutions, including Veeva Commercial Cloud and Veeva Claims Solutions, and R&D Solutions, encompassing Veeva Development Cloud, Veeva RegulatoryOne, and Veeva QualityOne Solutions. Veeva's solutions are built on the proprietary Veeva Vault platform, supporting clinical, regulatory, quality, and safety tasks within life sciences organizations.
IQVIA Inc.: Leader in eClinical Solutions and Research Outsourcing
IQVIA Inc. is a key player in life sciences research and commercial outsourcing, known for its advanced eClinical solutions that enhance data quality, patient experience, and clinical trial efficiency. The company's market leadership is bolstered by strategic acquisitions and collaborations, including its expansion in China, India, Russia, Turkey, and Japan. Notable developments include the May 2021 expansion of IQVIA Biotech in Japan and APAC and the acquisition of Q2 Solutions, which broadens its Research & Development Solutions offerings. IQVIA's efforts are focused on improving clinical and commercial solutions for biotech and emerging biopharma companies.
Request Sample Pages: [https://www.marketsandmarkets.com/requestsampleNew.asp?id=553&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]
Product Segmentation: EDC and CDMS Dominate the eClinical Solutions Market
The eClinical solutions market in 2023 is primarily driven by Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS). These segments are expected to hold the largest market share due to their ability to shorten clinical trial durations and costs, meet data standardization requirements, and accommodate increased R&D expenditures by pharmaceutical companies. EDC systems, for instance, have demonstrated significant cost savings in clinical trials. A notable example is Novartis, which used an open-source EDC platform across over 400 clinical trials, resulting in operational cost savings of USD 347,600 during a 12-month phase II trial conducted at 20 sites.
Regional Insights: North America Leads the Market
In 2023, North America is set to dominate the eClinical solutions market, followed by Europe and the Asia-Pacific region. Key drivers for North America's leading position include increased government funding for clinical trials, a high volume of ongoing clinical studies, continuous product advancements by eClinical solution providers, and numerous partnerships for drug development. The region also benefits from a high incidence of lifestyle diseases and an expanding aging population.
Growth Forecast: Asia-Pacific to Experience Highest Growth
The Asia-Pacific region is anticipated to achieve the highest growth rate in the eClinical solutions market during the forecast period. This growth is supported by increased outsourcing of clinical trials, less stringent regulatory environments compared to developed markets, and a large patient base. Additionally, significant investments and reforms are focused on modernizing healthcare infrastructure in China, growing the health industry in India, and adopting IT programs in Australia and New Zealand.
For more information, inquire now! [https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=553&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]
Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=eclinical-solutions-market-worth-221-billion-by-2029-driven-by-rising-chronic-illness-rates]
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/eclinical-solutions-market-553.html
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release eClinical Solutions Market worth $22.1 billion by 2029 driven by Rising Chronic Illness Rates here
News-ID: 4000092 • Views: …
More Releases from ABNewswire
Stocks Under $1 To Watch: $NITO, $SPRC, $PNPNF, $NCNA, $PRSO - Multi-Sectors Mom …
In today's market, investors are scanning for deeply undervalued stocks with disruptive technology, breakthrough clinical assets, and high-impact news catalysts. Several oversold equities trading under $1 have emerged with notable developments, drawing algorithmic attention across trading platforms, financial news networks, and Google-indexed search results.
N2OFF Inc. (NASDAQ: NITO), previously known as Save Foods, is building traction with its eco-friendly crop protection solutions. Focused on reducing pesticides, extending shelf life, and improving…
Biopreservation Industry Worth $7.1 billion by 2029, with a CAGR of 9.8%
The global biopreservation market, valued at US$3.7B in 2022, is forecasted to grow at a 9.8% CAGR, reaching US$4.4B by 2024 and US$7.1B by 2029.
In the rapidly evolving landscape of biopreservation, characterized by a market value estimated to be worth $4.4 billion in 2024 and poised to reach $7.1 billion by 2029, growing at a Compound Annual Growth Rate (CAGR) of 9.8%, industry leaders such as Thermo Fisher Scientific Inc.,…
Current Sensor Market worth $5.41 Billion by 2030, at a CAGR of 10.8%
The global Current Sensor Market Size in terms of revenue is estimated to be worth $3.24 billion in 2025 and is poised to reach $5.41 billion by 2030, growing at a CAGR of 10.8% during the forecast period.
The report "Current Sensor Market [https://www.marketsandmarkets.com/Market-Reports/current-sensor-market-26656433.html?utm_source=abnewswire.com&utm_medium=PaidPR&utm_campaign=CurrentSensormarket] by Measurement (Less than 10A, 10-100A, Above 100A), Offering (Isolated, Non-isolated), Technology (Hall-effect, AMR, GMR, TMR, Flux Gate, Current Sensing Amplifier, Opto-isolated and Shunt Isolated OP Amp)…
Edge AI Software Market 2025 Edition: Industry Size to Reach $8.88 Billion by 20 …
Edge AI Software Market by Offering (Platform, Frameworks & Toolkits), Technology (Generative AI, Machine Learning, NLP, Computer Vision), Data Modality (Spatial Data, Temporal Data, Visual Data, Multimodal Data, Textual Data) - Global Forecast to 2031.
The global edge AI software market [https://www.marketsandmarkets.com/Market-Reports/edge-ai-software-market-70030817.html?utm_campaign=edgeaisoftwaremarket&utm_source=abnewswire.com&utm_medium=paidpr] is expected to grow at a compound annual growth rate (CAGR) of 24.4% between 2025 and 2031, increasing from an estimated USD 2.40 billion in 2025 to USD 8.88…
More Releases for Clinical
Clinical Laboratory Market in Indonesia, Clinical Laboratory Industry in Indones …
"Increase in healthcare expenditure from the Indonesian government has driven the growth of clinical laboratory market in Indonesia."
Increase in Healthcare Awareness: Largely driven by increase in healthcare spending by aging population (~$ 260 per person by 2050), rising income levels, rising awareness for preventive testing, advanced healthcare diagnostic tests offerings, and central government's healthcare measures.
Developments in Testing and Preference for Evidence based testing: There is also a rising number…
Clinical solutions
Are you spending more time with yellow files than with patients? Healthbridge can change that with our intuitive and easy to use clinical platform that is designed specifically for the medical practitioner at the practice.
smaller2
Easily access patient
information
Cloud-based technology enables you to store rich clinical information that can be easily accessed as and when you need it.
Medical billing software innovation
Become a paperless
practice
Create scripts, sick notes, and clinical notes electronically. Plus, have…
Clinical Research and Clinical Trials Summit
Clinical Research 2019 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come join us at our event and make it successful by your participation.
This is the premier interdisciplinary forum for…
Paediatric Clinical Trial Conference - When designing a Paediatric clinical tria …
Press Release – 12.02.2018
When designing a Paediatric clinical trial, a paediatric investigation plan (PIP) is a development plan aimed at ensuring that the necessary data are obtained through studies in children, to support the authorisation of a medicine for children. All applications for marketing authorisation for new medicines have to include the results of studies as described in an agreed PIP, unless the medicine is exempt because of a deferral…
Clinical Communication
According to a recent market report published by Persistence Market Research titled “Clinical Communication and Collaboration Market: Global Industry Analysis (2012–2016) and Forecast (2017–2025),” revenue from the global clinical communication and collaboration market was US$ 138.5 Mn in 2012 and US$ 214.8 Mn in 2016, representing a CAGR of 11.6% from 2012 to 2016. This revenue growth is attributed to addition of new features in clinical communication and collaboration solutions.…
E-Clinical Trial Solutions Market To Accelerating Clinical Development Technolog …
The study of the "Global e-Clinical Trial Solutions Market" provides the market size information and market trends along with the factors and parameters impacting it in both short and long term. The study ensures a 360° view, bringing out the complete key insights of the industry.
The Global e-Clinical Trial Solutions Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the e-Clinical…
